AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The AIDPRO-CRC Trial

RecruitingNAAges 18 Years - anyAllZealand University Hospital
💬

In plain words

What the trial is, and whether it could suit you

The AIDPRO-CRC trial aims to improve outcomes for patients undergoing surgery for colorectal cancer by using artificial intelligence (AI) to assist surgeons in risk assessment. The trial will evaluate whether AI can help surgeons better predict the risk of complications and death, leading to improved care, fewer complications, and better use of healthcare resources. In this nationwide, randomized clinical trial, participants will be divided into two groups. One group will have their risk assessed by a surgeon using standard clinical methods, while the other group will have their risk assessed by a surgeon using AI assistance. Based on the risk level, patients will receive varying levels of perioperative care. The AI-assisted risk assessment aims to tailor the treatment more precisely to each patient's individual needs, precisely allocating care to those who need it to more efficiently a

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion criteria - patients To be eligible for study participation, the following criteria must be met: * Histologically confirmed diagnosis or strong clinical suspicion of first-time colon or rectal cancer, clinical stage I-IV. * Signed written informed consent obtained prior to any study-specific procedures. * Age ≥18 years at the time of consent. * Scheduled for potentially curative surgery as determined by a multidisciplinary team (MDT) conference. * Availability of all required input variables for the AI model not directly assessed by the surgeon (e.g., ASA score, WHO performance status). Exclusion criteria - patients A patient will be excluded from the study if: • Surgery with curative intent is no longer planned despite previous eligibility. Healthcare Professionals Surgeons and other healthcare professionals involved in the use of the AI-based platform will be invited to participate in two sub-studies: a user satisfaction survey and a simulation-based study. Eligible personnel will be automatically invited upon registration as platform users. Inclusion criteria - healthcare professionals To be eligible to participate in the survey and simulation study, individuals must: * Be licensed medical doctors. * Be either board-certified specialists in surgical oncology or currently in training to become one. Exclusion criteria - healthcare professionals There are no exclusion criteria for participation in the survey or simulation study.
💊

What it tests

  • AI augmented risk-stratification
  • Expert-based Risk-stratification
📍

Where

8 sites
Aalborg University Hospital, Department of Gastrointestinal Surgery
Aalborg, Denmark
Bispebjerg Hospital, University of Copenhagen, Digestive disease Center, Department of Surgery
Copenhagen NV, Denmark
Regional Hospital Gødstrup, Department of Surgery
Herning, Denmark
Copenhagen University Hospital - North Zealand, Hillerød, Department of Surgery
Hillerød, Denmark
Copenhagen University Hospital Hvidovre, Gastro Unit, Surgical Division
Hvidovre, Denmark
Regional Hospital Randers, Department of Surgery
Randers, Denmark
Odense University Hospital, Svendborg, Department of Colorectal Surgery
Svendborg, Denmark
Viborg Regional Hospital, Hospitalunit Midt, Department of Surgery
Viborg, Denmark
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy